Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Roundup: Church & Dwight Earnings, Nicoderm CQ Label Warning

This article was originally published in The Tan Sheet

Executive Summary

AstaZine carries 239 structure/function claims; FDA warns on misbranded supplements, cosmetics; Georgia joins NPLEx; and more news in brief.

You may also be interested in...



Drug-Spiked Coffee Recalled With Link To Death Suspected

Malaysian firm marketing spiked product states on its e-commerce site, "Warning … please make sure you are healthy enough to accept these wonderful new changes."

Weight Loss Claims Land Firms On FTC Radar In First ‘Negative Option’ Case

FTC says Health Formulas LLC of Las Vegas, and its associated firms in Nevada and California, make unsubstantiated claims for green coffee bean extract and other supplement products. A judge issued a temporary injunction against the firms from using “free” trial offers and deceptive health claims.

Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel

Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel